Senior Program Officer, Gynecology

The Foundation

We are the largest nonprofit fighting poverty, disease, and inequity around the world. Founded on a simple premise: people everywhere, regardless of identity or circumstances, should have the chance to live healthy, productive lives. We believe our employees should reflect the rich diversity of the global populations we aim to serve. We provide an exceptional benefits package to employees and their families which includes comprehensive medical, dental, and vision coverage with no premiums, generous paid time off, paid family leave, foundation‑paid retirement contribution, regional holidays, and opportunities to engage in several employee communities.

As a workplace, we’re committed to creating an environment for you to thrive both personally and professionally.

The Gender Equality Division’s mission is to ensure women and girls in Africa and South Asia can enjoy good health, make their own choices, earn their own money, and be leaders in their societies. When women and girls have an equal chance to thrive and lead, everyone benefits. We know that women and girls are not a monolith. A woman’s experience and the barriers she faces are different depending on factors like where she lives, how old she is, and how much money her family has—alongside other factors including her race, caste, and education level.

We seek to address these compounding barriers through deep partnership with our grantees. As a philanthropy, our role is to listen to and learn from these experts. We take risks in new areas, prove concepts, and bring these ideas to governments, partner organizations, and private sector companies to scale. The Gender Equality (GE) Division builds off our existing strengths as a foundation in areas like global health and data, partnering closely with all our global divisions.

The Women’s Health Innovations (WHI) team within the GE Division is a newly established group focused on developing and accelerating the introduction and scale‑up of interventions that disproportionately affect the health and economic outcomes of women and girls. WHI prioritizes three key areas: family planning and contraceptive technologies (CT), gynecological health, and sexually transmitted infections (STIs). In addition, the team focuses on two cross‑cutting areas: product introduction and market access, and strengthening the women’s health R&D ecosystem.

The Senior Program Officer, Gynecology (SPO) will lead a portfolio of investments and partnerships to support development and introduction of products to address high burden gynecologic conditions for women and girls in Low Middle‑Income Countries (LMICs). The SPO will collaborate with private sector partners, researchers and their institutions, global health organizations, professional societies, and government agencies, to align innovation with the needs of women and girls within LMIC health ecosystems.

We are seeking a technically skilled and strategically driven Senior Program Officer to lead initiatives that transform the landscape of the understanding and interventions for heavy menstrual bleeding (HMB) for women and girls in LMICs.

The ideal candidate will bring strong clinical perspectives for gynecologic care for HMB, have research and data generation expertise, product development experience, and a passion for addressing health barriers for women and girls in LMICs.

• Serve as an internal subject matter expert in gynecologic etiologies of heavy menstrual bleeding (HMB) and the relationship to anemia, as well as other key gynecologic conditions, such as vaginal dysbiosis.
• Develop a strategically aligned portfolio of investments focused on HMB
  • Identify and seek concepts for investments that align with WHI GYN strategy.
  • Closely manage a diverse portfolio of investments.
  • Work with grantees to ensure optimal output and impact of these investments.
• Lead WHI initiatives for HMB and gynecology/menstrual health (MH).
  • Collaborate with the data team to assess and address gaps in understanding of HMB etiology, prevalence, and burden, focusing on association with anemia and well‑being.
  • Assess efficacy of existing HMB treatments in…